YU28899A - Mikročestičasti oblik derivata tetrahidropiridina - Google Patents
Mikročestičasti oblik derivata tetrahidropiridinaInfo
- Publication number
- YU28899A YU28899A YU28899A YU28899A YU28899A YU 28899 A YU28899 A YU 28899A YU 28899 A YU28899 A YU 28899A YU 28899 A YU28899 A YU 28899A YU 28899 A YU28899 A YU 28899A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- micro
- particle form
- tetrahydropyridine derivative
- tetrahydropyridine
- derivative
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title abstract 2
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical class C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
- WVHBEIJGAINUBW-UHFFFAOYSA-N Xaliproden hydrochloride Chemical compound Cl.FC(F)(F)C1=CC=CC(C=2CCN(CCC=3C=C4C=CC=CC4=CC=3)CC=2)=C1 WVHBEIJGAINUBW-UHFFFAOYSA-N 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
Pronalazak se odnosi na mikročestičasti oblik 1-[2-(2-naftil)etil]-4-(3-tri-fluorometilfenil)-1,2,3,6-tetrahidropiridin hlorida koji se sastoji od čestica kod kojih najmanje 55 % populacije ima prečnik ispod 50 Вµm i na farmaceutske kompozicije u kojima se on nalazi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9615905A FR2757510B1 (fr) | 1996-12-23 | 1996-12-23 | Forme microparticulaire d'un derive de tetrahydropyridine |
Publications (2)
Publication Number | Publication Date |
---|---|
YU28899A true YU28899A (sh) | 2000-03-21 |
YU49427B YU49427B (sh) | 2006-01-16 |
Family
ID=9499044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU28899A YU49427B (sh) | 1996-12-23 | 1997-12-23 | Mikročestice derivata tetrahidropiridina |
Country Status (38)
Country | Link |
---|---|
US (4) | US20020028247A1 (sh) |
EP (1) | EP0950051B1 (sh) |
JP (2) | JP4422214B2 (sh) |
KR (1) | KR100455797B1 (sh) |
CN (1) | CN1088698C (sh) |
AR (1) | AR009673A1 (sh) |
AT (1) | ATE250032T1 (sh) |
AU (1) | AU730302B2 (sh) |
BR (1) | BR9714177A (sh) |
CA (1) | CA2275593C (sh) |
CO (1) | CO4920213A1 (sh) |
CZ (1) | CZ294272B6 (sh) |
DE (1) | DE69724999T2 (sh) |
DK (1) | DK0950051T3 (sh) |
DZ (1) | DZ2386A1 (sh) |
EE (1) | EE04112B1 (sh) |
EG (1) | EG24749A (sh) |
ES (1) | ES2207758T3 (sh) |
FR (1) | FR2757510B1 (sh) |
HK (1) | HK1024000A1 (sh) |
HU (1) | HU224348B1 (sh) |
IL (1) | IL129937A (sh) |
IN (1) | IN186977B (sh) |
IS (1) | IS2064B (sh) |
MY (1) | MY126298A (sh) |
NO (1) | NO311569B1 (sh) |
NZ (1) | NZ336129A (sh) |
PL (1) | PL190098B1 (sh) |
PT (1) | PT950051E (sh) |
RU (1) | RU2193031C2 (sh) |
SI (1) | SI0950051T1 (sh) |
SK (1) | SK283917B6 (sh) |
TR (1) | TR199901362T2 (sh) |
TW (1) | TW534820B (sh) |
UA (1) | UA66776C2 (sh) |
WO (1) | WO1998028272A1 (sh) |
YU (1) | YU49427B (sh) |
ZA (1) | ZA9711579B (sh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0210867A (pt) * | 2001-07-06 | 2004-06-29 | Lifecycle Pharma As | Processo para a preparação de um material particulado, métodos para aglomeração controlada de um material sólido finamente disperso, para melhorar a biodisponibilidade de uma substância terapêutica e/ou profilaticamente ativa, e para melhorar a vida em prateleira de uma composição farmacêutica, material articulado, composição farmacêutica, uso de um veìculo, material particulado farmacêutico, e, uso de aluminossilicato de magnésio e/ou de aluminometassilicato de magnésio |
BE1015641A4 (fr) * | 2003-05-26 | 2005-07-05 | Mariani Jean Paul | Micronisation 70. |
RU2472490C1 (ru) * | 2011-08-05 | 2013-01-20 | Открытое акционерное общество "Биосинтез" | Средство для лечения кожных гнойных инфекций, составы и способы получения |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US562883A (en) * | 1896-06-30 | Thill-coupling | ||
FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
FR2639226B1 (fr) * | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
EP0625069B1 (de) * | 1992-10-26 | 1998-12-30 | Schwarz Pharma Ag | Verfahren zur herstellung von mikrokapseln |
US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
US5662883A (en) * | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
US6489334B2 (en) * | 1996-12-23 | 2002-12-03 | Sanofi-Synthelabo | Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms |
FR2763847B1 (fr) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 |
US20020147216A1 (en) * | 2000-01-31 | 2002-10-10 | Yuhong Zhou | Mucin synthesis inhibitors |
-
1996
- 1996-12-23 FR FR9615905A patent/FR2757510B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-19 AR ARP970106030A patent/AR009673A1/es not_active Application Discontinuation
- 1997-12-22 MY MYPI97006232A patent/MY126298A/en unknown
- 1997-12-22 DZ DZ970236A patent/DZ2386A1/xx active
- 1997-12-23 KR KR10-1999-7005372A patent/KR100455797B1/ko not_active IP Right Cessation
- 1997-12-23 UA UA99063520A patent/UA66776C2/uk unknown
- 1997-12-23 CA CA002275593A patent/CA2275593C/en not_active Expired - Fee Related
- 1997-12-23 TR TR1999/01362T patent/TR199901362T2/xx unknown
- 1997-12-23 BR BR9714177-1A patent/BR9714177A/pt not_active Application Discontinuation
- 1997-12-23 CO CO97074790A patent/CO4920213A1/es unknown
- 1997-12-23 IL IL12993797A patent/IL129937A/en not_active IP Right Cessation
- 1997-12-23 WO PCT/FR1997/002394 patent/WO1998028272A1/fr active IP Right Grant
- 1997-12-23 EG EG138497A patent/EG24749A/xx active
- 1997-12-23 YU YU28899A patent/YU49427B/sh unknown
- 1997-12-23 EE EEP199900263A patent/EE04112B1/xx not_active IP Right Cessation
- 1997-12-23 DK DK97952987T patent/DK0950051T3/da active
- 1997-12-23 US US09/331,514 patent/US20020028247A1/en not_active Abandoned
- 1997-12-23 EP EP97952987A patent/EP0950051B1/fr not_active Expired - Lifetime
- 1997-12-23 HU HU0001181A patent/HU224348B1/hu not_active IP Right Cessation
- 1997-12-23 NZ NZ336129A patent/NZ336129A/xx not_active IP Right Cessation
- 1997-12-23 ES ES97952987T patent/ES2207758T3/es not_active Expired - Lifetime
- 1997-12-23 PL PL97334276A patent/PL190098B1/pl not_active IP Right Cessation
- 1997-12-23 SI SI9730592T patent/SI0950051T1/xx unknown
- 1997-12-23 IN IN3767DE1997 patent/IN186977B/en unknown
- 1997-12-23 CZ CZ19992291A patent/CZ294272B6/cs not_active IP Right Cessation
- 1997-12-23 AT AT97952987T patent/ATE250032T1/de active
- 1997-12-23 JP JP52848298A patent/JP4422214B2/ja not_active Expired - Fee Related
- 1997-12-23 SK SK829-99A patent/SK283917B6/sk not_active IP Right Cessation
- 1997-12-23 RU RU99116321/04A patent/RU2193031C2/ru not_active IP Right Cessation
- 1997-12-23 CN CN97180862A patent/CN1088698C/zh not_active Expired - Fee Related
- 1997-12-23 ZA ZA9711579A patent/ZA9711579B/xx unknown
- 1997-12-23 PT PT97952987T patent/PT950051E/pt unknown
- 1997-12-23 AU AU56685/98A patent/AU730302B2/en not_active Ceased
- 1997-12-23 DE DE69724999T patent/DE69724999T2/de not_active Expired - Lifetime
-
1998
- 1998-01-21 TW TW086119619A patent/TW534820B/zh not_active IP Right Cessation
-
1999
- 1999-06-10 IS IS5077A patent/IS2064B/xx unknown
- 1999-06-22 NO NO19993077A patent/NO311569B1/no not_active IP Right Cessation
-
2000
- 2000-05-30 HK HK00103194A patent/HK1024000A1/xx not_active IP Right Cessation
-
2002
- 2002-06-21 US US10/177,384 patent/US20020192292A1/en not_active Abandoned
-
2008
- 2008-06-13 US US12/138,582 patent/US20080255365A1/en not_active Abandoned
-
2009
- 2009-06-10 JP JP2009139083A patent/JP2009280581A/ja active Pending
- 2009-10-05 US US12/573,455 patent/US20100021541A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9701281A3 (en) | Piperidine derivatives as neurokinin antagonists and pharmaceutical compositions containing them | |
CY1110309T1 (el) | Φαρμακευτικες συνθεσεις για την προληψη και την αγωγη διαταραχων του κεντρικου νευρικου συστηματος περιλαμβανοντας ενα αναλογο νικοτινης και εναν αναστολεα ακετυλχολινεστερασης | |
ATE173255T1 (de) | 3-(5-tetrazolyl-benzyl) aminopiperidin-derivate und tachykinin antagonisten | |
ATA110894A (de) | Oral anwendbare und gegen plaque und gingivitis wirkende zusammensetzungen | |
MXPA04000849A (es) | Composicion cristalina que contiene escitalopram. | |
IL116917A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
HUP9904167A3 (en) | 1,4-disubstituted piperazine and piperidine derivatives, their use and pharmaceutical compositions containing the same | |
DZ2086A1 (fr) | Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant. | |
DE69601765T2 (de) | Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten | |
BR9602759A (pt) | Composição farmacêutica oral organoleticamente aceitável | |
HUP0003362A3 (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
DE69118198T2 (de) | Substituierte tetrahydropyridine und hydroxypiperidine als mittel zur behandlung des zentralen nervensystems | |
BR9602758A (pt) | Composição farmacêutica oral organoleticamente aceitável | |
DK1077941T3 (da) | Forbindelser med væksthormonfrigörende egenskaber | |
MX9203505A (es) | N-aril-n-(4-(1-alquilheterociclico)-piperidinil) amidas y composicines farmaceuticas y metodos que emplean dichos compuestos. | |
FR2730995B1 (fr) | Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
YU28899A (sh) | Mikročestičasti oblik derivata tetrahidropiridina | |
HUP9801382A3 (en) | Piperazine derivatives as neurokinin antagonists and pharmaceutical compositions containing these compounds | |
TR200000291T2 (tr) | Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler. | |
EE04235B1 (et) | Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks | |
DE59813233D1 (de) | Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione | |
HUP0000854A3 (en) | 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine derivatives, pharmaceutical compositions containing them and process for the preparation of both | |
HU9502509D0 (en) | Use of 1,4-dihydropyridine-3,5-dicarboxylic-acid-esters as active component of pharmaceutical compositions | |
IL120008A0 (en) | (1H-indol-4-YL)-piperidine or tetrahydropyridine ethylamines and ethylcarboxamides and pharmaceutical compositions containing them | |
RU99116321A (ru) | Форма производного тетрагидропиридина в виде микрочастиц |